Methoxetamine-related deaths in the UK: An overview

Human Psychopharmacology

Volumn 30, Issue 4, 2015, Pages 244-248

  Chiappini, Stefania ^a   Claridge, Hugh ^a   Corkery, John M ^a   Goodair, Christine ^a   Loi, Barbara ^a   Schifano, Fabrizio ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

designer drugs; legal high; methoxetamine; MXE; novel psychoactive substances; NPS

Indexed keywords

DESIGNER DRUG; KETAMINE; METHOXETAMINE; UNCLASSIFIED DRUG; 2-(3-METHOXYPHENYL)-2-(ETHYLAMINO)CYCLOHEXANONE; CYCLOHEXANONE DERIVATIVE; CYCLOHEXYLAMINE DERIVATIVE; STREET DRUG;

ADULT; AUTOPSY; CASE STUDY; CAUCASIAN; CAUSE OF DEATH; CONFERENCE PAPER; CORONER; DRUG INTOXICATION; DRUG OVERDOSE; ETHNICITY; FATALITY; FORENSIC TOXICOLOGY; HUMAN; METHOXETAMINE INTOXICATION; PRIORITY JOURNAL; SUBSTANCE ABUSE; UNITED KINGDOM; ADDICTION; ADOLESCENT; DIAGNOSIS; FEMALE; GREAT BRITAIN; MALE; MORTALITY; RETROSPECTIVE STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; CYCLOHEXANONES; CYCLOHEXYLAMINES; DIAGNOSIS; FEMALE; GREAT BRITAIN; HUMANS; MALE; RETROSPECTIVE STUDIES; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84938061631     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.2422     Document Type: Conference Paper

References (28)

1. ACMD. 2011. Consideration of the novel psychoactive substances ("legal highs"), 2011 -Publications-GOV.UK. [ONLINE] Available at: https://www.gov.uk/government/publications/novel-psychoactive-substances-report-2011. [Accessed 23 January 2014].
2. ACMD. 2012. Methoxetamine report, 2012- Publications-GOV.UK. [ONLINE] Available at: https://www.gov.uk/government/publications/advisory-council-on-the-misuse-of-drugs-acmd-methoxetamine-report-2012. [Accessed 23 January 2014].
3. Anand JS, Wiergowski M, Barwina M, Kaletha K,. 2012. Accidental intoxication with high dose of methoxetamine (MXE)-a case report. Przegl Lek 69: 609-10.
4. Ayres TC, Bond JW,. 2012. A chemical analysis examining the pharmacology of novel psychoactive substances freely available over the internet and their impact on public (ill) health. Legal highs or illegal highs? BMJ Open 2: e000977.
5. Yiu-Cheung C,. 2012. Acute and chronic toxicity pattern in ketamine abusers in Hong Kong. J Med Toxicol 8 (3): 267-70. doi: 10.1007/s13181-012-0229-z. PubMed PMID: 22552737; PubMed Central PMCID: PMC3550162.
6. Chiappini S, Claridge H, Gimeno Clemente C, Loi B, Goodair C,. 2013. Ketamine analogue Methoxetamine and related deaths in the UK during 2011-2012: descriptive and clinical characteristics of national programme on Substance Abuse Deaths (np-SAD) cases. (Poster presented at 2nd International Conference on Novel Psychoactive Substances) Available at: http://www.mededlive.co.uk/nps-social/documents/posters/Meth.pdf [Accessed 18 February 2014].
7. Corazza O, Assi S, Schifano F,. 2013. From Special K to Special M: the evolution of the recreational use of ketamine and methoxetamine. CNS Neurosci Ther 1-7.
8. Corkery J, Claridge H, Loi B, Goodiar C, and, Schifano F,. 2014. Drug-related deaths in the UK: January-December 2012, Annual Report 2013. [ONLINE]. Available at: http://www.sgul.ac.uk/research/projects/icdp/our-work-programmes/substance-abuse-deaths [Accessed 12 February 2014].
9. Daily mail. 2012. Student, 20, dies after taking legal high 'mexxy' a month before ban comes into force. [ONLINE]. Available at: http://www.dailymail.co.uk/news/article-2216873/Student-20-dies-taking-legal-high-mexxy-month-ban-comes-force.html [Accessed 7 May 2014].
10. EMCDDA-Europol. 2012. Annual report on the implementation of council decision 2005/387/JHA (New drugs in Europe, 2012). [ONLINE] Available at: http://www.emcdda.europa.eu/publications/implementation-reports/2012. [Accessed 23 January 2014].
11. EMCDDA-Europol. 2014. Joint Report on a new psychoactive substance: methoxetamine (2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone). January. [ONLINE] Available at: http://www.emcdda.europa.eu/attachements.cfm/att-222602-EN-EMCDDA-Europol-Joint%20Report-Methoxetamine.pdf. [Accessed 18 February 2014].
12. Hamilton EJ, Misselbrook GP,. 2012. Out with the old, in with the new? Case reports of the clinical features and acute management of two novel designer drugs. J Acute Med 11 (3): 157-160.
13. Hill SL, Harbon SCD, Coulson J, et al,. 2014. Methoxetamine toxicity reported to the National Poisons Information Service: clinical characteristics and patterns of enquiries (including the period of the introduction of the UK's first temporary Class Drug Order). Emerg Med J 00: 1-3. 31 (1): 45-7. doi: 10.1136/emermed-2012-202251. Epub 2013 Jan 24. PubMed PMID: 23349353.
14. Home Office. 2013. Control of synthetic cannabinoids. A Change to the Misuse of Drugs Act 1971: control of synthetic cannabinoids and related compounds. London: Home Office; 2013 (Circular 004/2013) [ONLINE] Available at: https://www.gov.uk/government/publications/circular-0042013-control-of-synthetic-cannabinoids. [Accessed 23 January 2014].
15. Hydzik P, Gomolka E, Sulka A, Cudzich-Czop S,. 2012. Acute methoxetamine poisoning-case report. J Forensic Sci 91: 235-242.
16. Kjellgren A, Jonsson K,. 2013. Methoxetamine (MXE)-a phenomenological study of experiences induced by a "legal high" from the Internet. J Psychoactive Drugs 45 (3): 276-286.
17. Łukasik-Głebocka M, Sommerfeld K, Tezyk A, Zielińska-Psuja B, Druzdz A,. 2013. Acute methoxetamine intoxication-a case report with serum and urine concentrations. Przegl Lek 70 (8): 671-3. Polish. PubMed PMID: 24466717.
18. Mixmag/Guardian Global Drugs Survey. 2012. Available at: http://glocaldrugsurvey.com/run-my-survey/2012-global-drug-survey. London: Mixmag/Guardian. Accessed 25 October 2013.
19. Morgan CJA, Curran HV,. 2011. Ketamine use: a review. Addiction 107: 27-38.
20. Rosenbaum CD, Carreiro SP, Babu KM,. 2012. Here today, gone tomorrow...and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (Bath salt), kratom, Salvia divinorum, Methoxetamine, and Piperazines. J Med Toxicol 8: 15-32.
21. Schifano F, Corkery J, Oyefeso A, Tonia T, Ghodse AH,. 2008. Trapped in the "K-hole": overview of deaths associated with ketamine misuse in the UK (1993-2006). J Clin Psychopharmacol 28 (1): 114-6.
22. Schmidt MM, Sharma A, Schifano F, Feinmann C,. 2012. 'Legal highs' on the net-evaluation of UK-based websites, products and product information. Forensic Sci Int 206: 92-97.
23. Shields JE, Dargan P, Wood DM, Puchnarewicz M, Davies S, Waring WS,. 2012. Methoxetamine associated reversible cerebellar toxicity: three cases with analytical confirmation. Clin Toxicol 50: 438-440.
24. TNI/IDPC. 2011. Series on legislative reform of drug policies Nr. 16-'legal highs': the challenge of new psychoactive substances. [ONLINE] Available at: http://idpc.net/publications/2011/10/legal-highs-the-challenge-of-new-psychoactive-substances. [Accessed 23 January 2014].
25. Westwell AD, Hutchings A, Caldicott DGE,. 2013. The identification and chemical characterization of a new arylcyclohexylamine, methoxetamine, using a novel emergency department toxico surveillance tool. Drug Test Anal 5: 203-207.
26. Wikström M, Thelander G, Dahlgren M, Kronstrand R,. 2013. An accidental fatal intoxication with methoxetamine. J Anal Toxicol 37 (1): 43-6.
27. Wood DM, Davies S, Puchnarewicz M, Johnston A, Dargan PI,. 2011. Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine. Eur J Clin Pharmacol 68 (5): 853-856.
28. Wood DM, Greene SL, Dargan PI,. 2013. Five-year trends in self-reported recreational drugs associated with presentation to a UK emergency department with suspected drug-related toxicity. Eur J Emerg Med 20: 263-267.